- Home
- AVIR vs IMXI Comparison
AVIR vs IMXI Comparison
Compare AVIR & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- IMXI
- Stock Information
- Founded
- AVIR 2012
- IMXI 1994
- Country
- AVIR United States
- IMXI United States
- Employees
- AVIR N/A
- IMXI N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- IMXI Retail: Computer Software & Peripheral Equipment
- Sector
- AVIR Health Care
- IMXI Technology
- Exchange
- AVIR Nasdaq
- IMXI Nasdaq
- Market Cap
- AVIR 277.8M
- IMXI 278.2M
- IPO Year
- AVIR 2020
- IMXI N/A
- Fundamental
- Price
- AVIR $3.50
- IMXI $14.42
- Analyst Decision
- AVIR Hold
- IMXI Buy
- Analyst Count
- AVIR 1
- IMXI 6
- Target Price
- AVIR $6.00
- IMXI $19.60
- AVG Volume (30 Days)
- AVIR 361.0K
- IMXI 1.2M
- Earning Date
- AVIR 08-07-2025
- IMXI 08-11-2025
- Dividend Yield
- AVIR N/A
- IMXI N/A
- EPS Growth
- AVIR N/A
- IMXI N/A
- EPS
- AVIR N/A
- IMXI 1.65
- Revenue
- AVIR N/A
- IMXI $642,149,000.00
- Revenue This Year
- AVIR N/A
- IMXI N/A
- Revenue Next Year
- AVIR N/A
- IMXI $2.93
- P/E Ratio
- AVIR N/A
- IMXI $8.76
- Revenue Growth
- AVIR N/A
- IMXI N/A
- 52 Week Low
- AVIR $2.46
- IMXI $8.58
- 52 Week High
- AVIR $4.15
- IMXI $22.37
- Technical
- Relative Strength Index (RSI)
- AVIR 48.71
- IMXI 77.14
- Support Level
- AVIR $3.33
- IMXI $9.19
- Resistance Level
- AVIR $3.60
- IMXI $15.27
- Average True Range (ATR)
- AVIR 0.16
- IMXI 0.35
- MACD
- AVIR -0.02
- IMXI 0.67
- Stochastic Oscillator
- AVIR 26.69
- IMXI 87.29
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.